Health 2.0

By Tom Sullivan April 19, 2017
Today, HIMSS announced it is acquiring Health 2.0, the conference organization focused on healthcare technology innovation. HIMSS CEO H. Stephen Lieber said that while HIMSS has traditionally focused on mainstream technologies deployed by hospitals, networks and physician groups, the acquisition will make it possible for HIMSS to have a greater influence on the cutting edge of health IT. “We will...
By MobiHealthNews September 30, 2016
This week in Santa Clara marked the 10th anniversary for Health 2.0, a health tech conference held every year in Silicon Valley to explore the progress being made in the digital health space and the challenges that remain. MobiHealthNews was onsite all four days of the conference and below we’ve rounded up our coverage of the event, plus quite a few presentations and bits of news that didn’t make...
By Heather Mack September 30, 2016
The shift of government, the private sector and consumers of coming together to tackle the biggest problems in healthcare is starting to show, and the best indication is the innovation in digital health. But in order to do more, all parties must continue working together and providing opportunities in the form of policies, partnerships and information. That was the takeaway from a speech by Karen...
By Heather Mack September 30, 2016
Sleep – the final frontier, or so it seems in digital health. While everybody needs sleep and plenty want to know more about how to do it the best they can, tools to improve sleep and, in turn, improve health have moved decidedly slower than other digital health innovations like activity trackers. But that’s changing, said a panel of sleep experts and sleep tracking device and app makers at...
By Heather Mack September 30, 2016
What does the next generation health consumer look like? If you ask the folks at Health 2.0 in Santa Clara, it depends on the technology you give them to make healthy choices.   In a session at focused on the consumerization and disruption of traditional care models, we heard from several providers, startups and established medical device makers on the new digital health tools they are equipping...
By Heather Mack September 28, 2016
As part of an initiative from Health 2.0’s Technology for Healthy Communities, a Medi-Cal managed care organization will get an infusion of digital health tools to better serve their at-risk community. The San Leandro-based Community Health Center Network is partnering with San Francisco-based Welkin Health, which specializes in patient relationship management through messaging services and...
By Heather Mack September 28, 2016
Chronic disease management not only eats up upwards of 85 percent of US healthcare spending, it also accounts for seven out of 10 US deaths per year. So innovation in this sector is critical, but must take many forms, a panel of digital health companies said at Health 2.0. “We can quote, all day, stats for chronic disease spending, and if we don’t work to reverse this trend, that amount will...
By Heather Mack September 28, 2016
This year has proven to be a time of reckoning for digital health funding, with few IPOs living up to their expectations, venture capital funds becoming more selective, and scrutiny of startups increasing, said a panel of investors at Health 2.0 in Santa Clara. That said, however, money is still flowing into the industry, but expect a shift in the next year, with more private-to-private mergers...
By Heather Mack September 27, 2016
Palo Alto-based healthcare app and analytics platform Medable announced the launch of Axon, a SmartStudy system that enables researchers to create and deploy ResearchKit app for clinical trials or research studies on their own, without having to work with a developer. The company formally introduced the offering at Health 2.0 in Santa Clara.  “Once ReasearchKit came out, we immediately saw a huge...
By Jonah Comstock September 27, 2016
The future of pharma is going to involve some major culture shifts for a business that has long been focused on slow development cycles, proprietary molecules, and close-held secrets. That’s the word from representatives from Bayer, Boehringer Ingelheim, Healthware International and BTG, a group that ran the gamut from small to big pharma at yesterday’s Pharma Roundtable onsite at Health 2.0 in...